Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Vox Sang ; 119(4): 300-307, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38156553

RESUMO

BACKGROUND AND OBJECTIVES: Risk factors for vasovagal reaction (VVR) have been extensively studied. With knowledge of the relative importance of these risk factors for VVR, collection staff could take care of blood donors from the same standpoint, leading to improved donor safety. We therefore developed a scoring system to predict VVR, which incorporates registration information. MATERIALS AND METHODS: Pre-syncopal and syncopal symptoms, as well as on- and off-site reactions, are included in this analysis as VVR. We defined the donor status as follows: first-time donors, repeat donors with no history of reaction and repeat donors with a history of reaction. We prepared two datasets: whole-blood donations at a blood donation site in Tokyo between January 2019 and December 2019 were included in training data (n = 361,114), and whole-blood donations between January 2020 and August 2020 were included in testing data (n = 216,211). RESULTS: The most important variable was the donor status, followed by age, estimated blood volume and height. We integrated them into a scoring system. Training and testing datasets were combined (n = 577,325), and VVR rates in groups with scores of 0, 1, 2, 3, 4 and 5 or more were 0.09% (95% CI: 0.081%-0.10%), 0.33% (95% CI: 0.31%-0.36%), 0.87% (95% CI: 0.78%-0.96%), 1.17% (95% CI: 1.05%-1.30%), 2.15% (95% CI: 1.98%-2.32%) and 3.11% (95% CI: 2.90%-3.34%), respectively. CONCLUSION: The scoring system enables staff to significantly predict VVR and may help them to identify donors at increased risk of experiencing syncope, thereby mitigating the negative impact of VVR on donor safety and return by paying close attention to high-risk donors.


Assuntos
Doação de Sangue , Síncope Vasovagal , Humanos , Doadores de Sangue , Síncope Vasovagal/diagnóstico , Síncope Vasovagal/epidemiologia , Síncope Vasovagal/etiologia , Fatores de Risco , Volume Sanguíneo
2.
J Obstet Gynaecol Res ; 48(7): 1989-1996, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-35614528

RESUMO

Fetoscopic laser surgery occasionally causes amniotic band syndrome, in which the disrupted amniotic membrane constricts fetal body parts, leading to functional or morphological loss. We report a case of fetal distress at 31 weeks of gestation in the larger surviving twin after fetoscopic laser surgery for selective intrauterine growth restriction, necessitating emergent cesarean section. Physical examination of the infant showed constriction rings caused by a disrupted amniotic membrane on the digits, and the distal part of the right index finger was necrotic because of tight strangulation by an amniotic band with the umbilical cord of the deceased smaller twin. Laboratory data showed severe coagulopathy, and the infant was diagnosed with disseminated intravascular coagulation (DIC). Immediate treatment improved his condition. DIC may have been associated with the necrotic finger, which was strangulated by the umbilical cord of the deceased fetus, because neither maternal coagulopathy nor an underlying neonatal disorder was detected.


Assuntos
Síndrome de Bandas Amnióticas , Coagulação Intravascular Disseminada , Transfusão Feto-Fetal , Terapia a Laser , Síndrome de Bandas Amnióticas/complicações , Síndrome de Bandas Amnióticas/cirurgia , Cesárea/efeitos adversos , Coagulação Intravascular Disseminada/complicações , Feminino , Transfusão Feto-Fetal/complicações , Transfusão Feto-Fetal/cirurgia , Fetoscopia/efeitos adversos , Humanos , Recém-Nascido , Fotocoagulação a Laser/efeitos adversos , Gravidez , Cordão Umbilical
3.
Taiwan J Obstet Gynecol ; 60(5): 874-877, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34507664

RESUMO

OBJECTIVE: Cystic hygroma often ameliorates or disappears with pregnancy progression. Fetuses/neonates with amelioration, when without chromosomal or major structural abnormality, generally show a favorable outcome at birth. The present study was aimed to clarify the short/long-term outcomes of fetuses/neonates with the amelioration of cystic hygroma during pregnancy. MATERIAL AND METHODS: This was a retrospective observational study. We focused on fetuses with cystic hygroma managed in our institute between January 2006 and June 2019. The infants were followed by pediatricians (neonatologist, pediatric cardiologist, and pediatric neurologist) and pediatric outcomes were retrieved from the medical records up to 3 years old. RESULTS: One hundred and seven fetuses with cystic hygroma were included. Of the 107, cystic hygromas ameliorated in 31 fetuses (31/107: 29%). Of the 31, there were 26 livebirths. Half (n = 13) of the 26 fetuses had a good outcome, whereas the remaining half (n = 13) had abnormalities. Various abnormalities were detected in their infancies. A nuchal thickness (diameter of hygroma) of ≥5 mm was significantly correlated with abnormalities (P = 0.047). CONCLUSION: Physicians should pay attention to fetuses/neonates with ameliorated cystic hygroma. Of those, special attention should be paid to fetuses/neonates with a nuchal thickness at diagnosis ≥5 mm.


Assuntos
Feto , Hidropisia Fetal , Linfangioma Cístico , Aberrações Cromossômicas , Anormalidades Congênitas , Feminino , Morte Fetal/etiologia , Humanos , Hidropisia Fetal/diagnóstico por imagem , Recém-Nascido , Linfangioma Cístico/complicações , Linfangioma Cístico/diagnóstico por imagem , Linfangioma Cístico/genética , Gravidez , Resultado da Gravidez , Primeiro Trimestre da Gravidez , Estudos Retrospectivos , Ultrassonografia Pré-Natal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA